Foghorn Therapeutics had a revenue of 8.15M in the quarter ending Sep 30, 2025, with 7.89%. This bring the company's revenue in the last twelve months to 24.52M, Decreased 1.43%. In the fiscal year ending Dec 31, 2024, Foghorn Therapeutics had annual revenue of 22.60M with -33.83% growth.